As such, our new guidance ranges are as follows: Total revenue for 2025 is now expected to be in the range of $525,000,000 to $565,000,000 compared to our prior guidance range of $510,000,000 to $550,000,000 GAAP net income for 2025 is now expected to be in the range of $5,000,000 to $26,000,000 compared to our prior guidance range of net loss of $10,000,000 to net income of $15,000,000 Adjusted EBITDA for 2025 is now expected to be in the range of 55,000,000 to 75,000,000 compared to our prior guidance range of 35,000,000 to $60,000,000 We continue to expect operating cash flow to be in the range of negative $25,000,000 to positive $10,000,000 These ranges include estimated positive net adjustment revenue in the range of 29 to $32,000,000 compared to the prior range of $11,000,000 to $20,000,000 Looking to Q3, we expect a year over year decline in revenue and adjusted EBITDA, driven by the same regulatory changes pertaining to dual eligible beneficiaries that impacted our Medicare Advantage enrollment volumes this quarter. As we ramp our telesales organization ahead of the AEP and invest in training our advisors, we also expect to carry greater CC and E costs compared to the second quarter.